Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 1, 2011, Pages 147-156

  Van Der Speeten, Kurt ^a   Stuart, O Anthony ^b   Chang, David ^c   Mahteme, Haile ^d   Sugarbaker, Paul H ^b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b WASHINGTON CANCER INSTITUTE   (United States)

^c WESTAT   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Appendix cancer; Chemotherapy pharmacokinetics; Colorectal cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy (HIPEC); Intraperitoneal chemotherapy; Mitomycin C

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADULT; AGED; APPENDIX CANCER; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL FLUID; PERITONECTOMY; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; URINARY EXCRETION; URINE VOLUME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; RETROPERITONEAL NEOPLASMS; YOUNG ADULT;

EID: 79959596599     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1460-4     Document Type: Article

References (41)

1. Verwaal VJ, Bruin S, Boot H, Van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426-2432
2. Sugarbaker PH (2009) Epithelial appendiceal neoplasms. Cancer J 15:225-235
3. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC (1981) Enhancement by hyperthermia of the in vitro cytotoxicity of Mitomycin C toward hypoxic tumor cells. Cancer Res 41:1096-1099
4. Urano M, Kuroda M, Nishimura Y (1999) For the clinical application of thermo chemotherapy given at mild temperatures. Int J Hyperthermia 15:79-107 (Pubitemid 29149801)
5. Link KH, Leder G, Pillasch J, Butzer U, Staib L, Kornmann M, Bruckner U, Beger HG (1998) In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Semin Surg Oncol 14:189-201
6. Fujita T, Tamura T, Yamada H, Yamamoto A, Muranishi S (1997) Pharmacokinetics of mytomycin C(MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice. J Drug Target 4:289-296
7. Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum( II) and mitomycin C. Cancer Res 40:1165-1168
8. Gilly FN, Carry PY, Sayag AC, Panteix G, Manchon M, Rochette A, Peix JL, Baulieux J, James I, Braillon G (1992) Tolerance of intraperitoneal chemohyperthermia with mitomycin C: in vivo study in dogs. Int J Hyperthermia 8:659-666
9. Murphy EM, Sexton R, Moran BJ (2007) Early results of surgery in 123 patients with pseudomyxoma peritonei from perforated appendiceal neoplasm. Dis Colon Rectum 50:37-42 (Pubitemid 46147019)
10. Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, Rai SN (2010) Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer 20:61-69
11. Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S (2008) Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34:1246-1252
12. Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M (2009) Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 16:463-472
13. Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43(Suppl):S15-S25
14. Esquivel J (2009) Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer J 15:249-254
15. Van Ruth S, Verwaal VJ, Zoetmulder FAN (2003) Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 12:771-780 (Pubitemid 36920098)
16. Elias DM, Sideris L (2003) Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am 12:755-769 (Pubitemid 36920097)
17. Sugarbaker PH, Stuart OA, Carmignani CP (2006) Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. Cancer Chemother Pharmacol 57:703-708
18. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29-42
19. De Lima Vazquez V, Sugarbaker PH (2003) Total anterior parietal peritonectomy. J Surg Oncol 83:261-263 (Pubitemid 36936013)
20. De Lima Vazquez V, Sugarbaker PH (2003) Cholecystectomy, lesser omentectomy and stripping of the omental bursa, a peritonectomy procedure. J Surg Oncol 84:45-49 (Pubitemid 37075695)
21. Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, Pignon JP, Drouard-Troalen L, Ouellet JF, Ducreux M (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13:267-272
22. Jacquet P, Sugarbaker PH (1996) Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15:49-58 (Pubitemid 26130826)
23. Dalton JT, Geuns ER, Au JL (1989) High performance liquid chromatography determination of mitomycin C in rat and human plasma and urine. J Chromatogr Biomed Appl 495:330-337 (Pubitemid 19270580)
24. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH (1998) Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology 55:130-138 (Pubitemid 28052257)
25. Wientjes MG, Dalton JT, Badalament RA, Drago JR, Au JL (1991) Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res 51:4347-4354
26. Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclément E, Vignal J, Gilly FN (2000) Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2512-2519
27. Loggie BW, Fleming RA (1996) Complications of heated intraperitoneal chemotherapy and strategies for prevention. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer Academic Publishers, Boston, pp 221-233
28. Fernandez-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH (1996) Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Cancer Treat Res 81:51-61
29. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T (1998) Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61:232-237
30. Fujimoto S, Shrestha RD, Kokobun M, Kobayashi K, Kiuchi S, Konno C, Koike S, Okui K (1989) Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 2:198-202
31. Panteix G, Guillaumont M, Cherpin L, Cuichard J, Gilly FN, Carry PY, Sayag A, Salle B, Brachet A, Bienvenu J (1993) Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 50:366-370 (Pubitemid 23274008)
32. Chang E, Alexander HR, Libutti SK, Hurst R, Zhai S, Figg WD, Bartlett DL (2001) Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 193:225-229 (Pubitemid 32729627)
33. De Lima Vazquez V, Stuart OA, Sugarbaker PH (2003) Extent of a parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol 52:108-112 (Pubitemid 37041342)
34. Elias D, Matsuhisa T, Sideris L, Liberale G, Drouard-Troalen L, Raynard B, Pocard M, Puizillou JM, Billard V, Bourget P, Ducreux M (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15:1558-1565 (Pubitemid 39409748)
35. Dedrick RL (1985) Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 12(3 Suppl 4):1-6
36. Flessner MF, Fenstermacher JD, Dedrick RL, Blasberg RG (1985) A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol 248:F425-F435 (Pubitemid 15142313)
37. Flessner MF (2005) The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 288:433-442
38. Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D (2008) Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 15:339-344
39. Thomas F, Ferron G, Gesson-Paute A, Hristova M, Lochon I, Chatelut E (2008) Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 15:3623-3624
40. Khatri VP (2010) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient? J Clin Oncol 28:5-7
41. Bachur NR, Gordon SL, Gee MV, Kon H (1979) NADPH cytochrome P-450 reductase activation of quinine anticancer agents to free radicals. Proc Natl Acad Sci USA 2:954-957 (Pubitemid 9130981)